Dr. Drezner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Michigan Ave NW
Washington, DC 20010Phone+1 202-476-5000Fax+1 202-476-5988
Education & Training
Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 2012 - 2015
Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterResidency, Pediatrics, 2008 - 2012
St. George's University School of MedicineClass of 2008
Certifications & Licensure
DC State Medical License 2012 - 2024
NY State Medical License 2011 - 2013- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 18 citationsFDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.Elizabeth S Duke, Liza Stapleford, Nicole Drezner, Anup K Amatya, Pallavi S Mishra-Kalyani
Clinical Cancer Research. 2023-02-01 - 118 citationsFDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC.Erica C Nakajima, Nicole Drezner, Xiaoxue Li, Pallavi S Mishra-Kalyani, Yajun Liu
Clinical Cancer Research. 2022-04-14 - 128 citationsCurrent Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer.Gideon M. Blumenthal, Paul A. Bunn, Jamie E. Chaft, Caroline E. McCoach, Edith A. Perez
Journal of Thoracic Oncology. 2018-12-01
Press Mentions
- FDA Panel Endorses DFMO for Kids' High-Risk Neuroblastoma in RemissionOctober 6th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
